Higher risk of liver cancer seen in women with intrahepatic cholestasis of pregnancy
the ONA take:
Researchers at the Sahlgrenska Academy found that women with intrahepatic cholestasis of pregnancy (ICP) are at increased risk of hepatobiliary cancer and immune-mediated and cardiovascular diseases later in life.
Using the Swedish Medical Birth Register and the Swedish Patient Register, the investigators identified 11,388 women with ICP and 113,893 women without ICP who gave birth between 1973 and 2009.
Study findings showed risk for cancer in the biliary tree and risk for liver cancer were 2.5 times higher and 3.5 times higher, respectively, compared with matched controls. In addition, patients with ICP were found to be at higher risk for thyroid disease, diabetes, psoriasis, and Crohn’s disease. Women with both ICP and preeclampsia during pregnancy had a slightly higher risk for cardiovascular disease.
The investigators recommend follow-up of serum liver tests 6 to 12 weeks after delivery for all women with ICP, and further evaluation by a hepatologist if serum liver tests results are elevated.
Women with intrahepatic cholestasis of pregnancy (ICP) are at increased risk of hepatobiliary cancer.
Sign Up for Free e-newsletters
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- A Witness to Letting Go: Nursing Care at the End of Life
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Modified XELIRI Noninferior to FOLFIRI for OS in Metastatic Colorectal Cancer
- Nabilone Improves Cancer-Associated Anorexia in Lung Cancer
- Direct-to-Consumer Genetic Test for Select BRCA Mutations Gets FDA Nod
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|